Researchers Use Nanoparticles to Test Treatment for Liver Disease

June 25, 2018 | Katie Neith

In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.

Continue Reading

Pregnant with Cancer: One Patient’s Remarkable Journey

August 15, 2018 | Alison Shore

City of Hope's I. Benjamin Paz, M.D., recognizes the unique dilemma of cancer during pregnancy because mapping the treatment course must consider two lives.

What Is Metastatic Triple-negative Breast Cancer?

July 30, 2018 | Kevin Chesley

City of Hope's Yuan Yuan, M.D., Ph.D, knows that those faced with metastatic triple-negative breast cancer have a tough fight ahead of them, but she is working to make that battle more surmountable.

‘Faces of Disparity’: A Month-long Exploration of Minority Health Issues

April 4, 2017 | Stephanie Smith

City of Hope is dedicating every day in April, National Minority Health Month, to beginning to examine important issues of disparity in health care.

New Study: Deploying Genetic Screens Early May Offer Some Benefits

February 7, 2017 | Jyoti Madhusoodanan

Next-generation sequencing (NGS) tests can quickly pinpoint tumor mutations that can be targeted with specific drugs, offering a route to precision therapies for many cancer types. Coupled with new drugs that target tumor-specific genomic changes, NGS tests carry the potential to transform modern cancer care.

Researcher receives grant to study aggressive form of breast cancer

June 22, 2016 | Michael Easterling

Victoria Seewaldt, M.D., the Ruth Ziegler professor and chair in the Department of Population Sciences at City of Hope, has received a two-year grant from the Prevent Cancer Foundation to support her research in early detection and triple-negative breast cancer, a highly aggressive form of cancer.

ASCO 2015: Clinical trial assesses options for triple-negative breast cancer

May 28, 2015 | Nicole Levine

A clinical trial currently being conducted at City of Hope and elsewhere suggests that researchers are developing improved treatment options for young women with advanced triple-negative breast cancer, a particularly difficult-to-treat disease.

Triple-negative breast cancer patient Homa Sadat: What I learned

January 22, 2015 | Nicole White

No one ever plans to have cancer – and there’s never a good time. For Homa Sadat, her cancer came at a particularly bad time: just one year after losing her father to the pancreatic cancer he had battled for two years.

Clinical trial for triple-negative breast cancer shows promise

January 15, 2015 | Nicole White

When Homa Sadat found a lump in her breast at age 27, her gynecologist told her what many doctors say to young women: You’re too young to have breast cancer. Triple-negative breast cancer is diagnosed at a higher rate in patients with BRCA-related breast cancer and in African-American women.

Cancer 2015: Liver cancer expert offers view from the front lines

December 24, 2014 | Tami Dennis

Yuman Fong, M.D., is an internationally recognized expert in hepatobiliary cancer – that is liver cancer, pancreatic cancer, gallbladder cancer and cancer of the bile ducts. He's also renowned for his use of genetically modified viruses to combat malignant disease, is a pioneer in the operating room and the laboratory, is the author of more than 600 peer-reviewed articles and 11 textbooks, and is the chair of the Department of Surgery at City of Hope.

Breast cancer survivor Becky Stokes: Shaving head is empowering, brave

September 24, 2014 | Nicole White

Runners prize medals for 5Ks and marathons. Becky Stokes has a medal she cherishes from a very different kind of race: the marathon of treatments necessary to beat her aggressive triple-negative breast cancer.